Financial reports
10-Q
2024 Q1
Quarterly report
10 May 24
10-K/A
2023 FY
Annual report (amended)
29 Apr 24
10-K
2023 FY
Annual report
22 Mar 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
11 Aug 23
10-Q
2023 Q1
Quarterly report
12 May 23
10-K
2022 FY
Annual report
31 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
12 Aug 22
Current reports
8-K
Submission of Matters to a Vote of Security Holders
20 Dec 23
8-K
Creative Medical Technology Holdings Regains Compliance With Nasdaq Listing Requirements
28 Jun 23
8-K
Creative Medical Technology Holdings Announces Reverse Stock Split
9 Jun 23
8-K
Submission of Matters to a Vote of Security Holders
19 Dec 22
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
14 Jul 22
8-K
Entry into a Material Definitive Agreement
4 May 22
8-K
Entry into a Material Definitive Agreement
4 May 22
8-K
Departure of Directors or Certain Officers
11 Feb 22
8-K
Creative Medical Technology Holdings, Inc. Prices $16 Million Public Offering and Uplisting to the Nasdaq Capital Market
7 Dec 21
8-K
Material Modifications to Rights of Security Holders
9 Nov 21
Registration and prospectus
424B3
Prospectus supplement
20 May 22
S-3
Shelf registration
10 May 22
D
$17M in equity / options, sold $17M, 18 investors
5 May 22
RW
Registration withdrawal request
4 May 22
S-1
IPO registration
22 Apr 22
424B4
Prospectus supplement with pricing info
6 Dec 21
8-A12B
Registration of securities on exchange
2 Dec 21
S-1/A
IPO registration (amended)
2 Dec 21
S-1/A
IPO registration (amended)
1 Dec 21
S-1/A
IPO registration (amended)
23 Nov 21
Proxies
DEF 14A
Definitive proxy
3 Nov 23
DEF 14A
Definitive proxy
26 Oct 22
DEF 14C
Information statement
24 Sep 21
PRE 14C
Preliminary information
7 Sep 21
DEFR14C
Revised information
3 Jan 20
DEF 14C
Information statement
22 Nov 19
PRE 14C
Preliminary information
5 Nov 19
DEF 14C
Information statement
13 Sep 19
PRE 14C
Preliminary information
30 Aug 19
DEF 14C
Information statement
31 Jan 18
Other
EFFECT
Notice of effectiveness
20 May 22
CORRESP
Correspondence with SEC
17 May 22
UPLOAD
Letter from SEC
16 May 22
EFFECT
Notice of effectiveness
3 Dec 21
CERT
Certification of approval for exchange listing
2 Dec 21
CORRESP
Correspondence with SEC
2 Dec 21
UPLOAD
Letter from SEC
2 Dec 21
CORRESP
Correspondence with SEC
30 Nov 21
CORRESP
Correspondence with SEC
30 Nov 21
CORRESP
Correspondence with SEC
23 Nov 21
Ownership
4
Timothy Warbington
29 Jun 23
SC 13G/A
Markey John
26 May 23
SC 13G
Markey John
1 May 23
4
Timothy Warbington
23 Nov 22
4
Michael H. Finger
29 Sep 22
4
Timothy Warbington
28 Sep 22
4
Timothy Warbington
22 Sep 22
4
Michael H. Finger
14 Jun 22
4
Timothy Warbington
7 Jun 22
4
Michael H. Finger
20 May 22